AVR 0.00% $18.31 anteris technologies ltd

Ann: FIH Results Presented at EuroPCR & Simultaneous Publication, page-4

  1. 493 Posts.
    lightbulb Created with Sketch. 307
    Very interesting.....

    When Mr Paterson talked about 35-40 patients by years end in interviews before I was always curious where those EXTRA patients would come from as 13 (FIH study) and 15 (EFS study) only added up to 28!

    So now we have our answer.

    As a side note, in all of my years reading commentary from doctors and scientists on results, I've gotten used to them describing describing even the most amazing results in restrained terms, until now....

    “In the short-term, the haemodynamics are amazing, and that’s one of the things I’m excited
    about…"

    A very strong and enthusiastic reaction here from,

    Susheel Kodali, MD, Columbia University Irving Medical Center, New York, USA, first author
    on the publication and an Investigator in the FIH study.

    I think every AVR shareholder right now should be feeling just as excited, we're onto something very very big!
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.31
Change
0.000(0.00%)
Mkt cap ! $351.9M
Open High Low Value Volume
$18.30 $19.00 $18.00 $363.4K 19.82K

Buyers (Bids)

No. Vol. Price($)
2 500 $18.13
 

Sellers (Offers)

Price($) Vol. No.
$18.50 1000 1
View Market Depth
Last trade - 15.59pm 01/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.